Supernus SUPN
NASDAQ SUPN
$28.75 +1.13 (+4.09%)
At close: Nov 10, 2026 · 4:00 PM EST

Supernus (SUPN) Preferred Shares (2011 - 2012)

Updated

Supernus Pharmaceuticals (SUPN) recorded Preferred Shares of $49,000 in Q1 2012, unchanged from the prior quarter.

Analysis

Supernus (SUPN) Preferred Shares (2011 - 2012) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Supernus 1.62 Bn 196.50 Mn 199.75 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2012 49,000.00
Dec 31, 2011 49,000.00
API Access

Supernus Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=SUPN&period=max&api_key=YOUR_API_KEY